A.R.T. Advisors’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-112,765
Closed -$576K 1096
2019
Q4
$576K Sell
112,765
-15,180
-12% -$51.5K 0.03% 787
2019
Q3
$310K Sell
127,945
-26,957
-17% -$71.6K 0.02% 1035
2019
Q2
$336K Sell
154,902
-290,216
-65% -$686K 0.02% 910
2019
Q1
$1.21M Buy
+445,118
New +$1.93M 0.07% 415
2018
Q4
Sell
-48,745
Closed -$461K 1746
2018
Q3
$461K Buy
+48,745
New +$469K 0.02% 888
2018
Q2
Sell
-92,456
Closed -$972K 1831
2018
Q1
$972K Buy
+92,456
New +$913K 0.04% 678
2017
Q4
Sell
-166,036
Closed -$1.27M 1739
2017
Q3
$1.27M Buy
+166,036
New +$1.1M 0.06% 441
2016
Q3
Sell
-84,049
Closed -$258K 1245
2016
Q2
$258K Buy
+84,049
New +$527K 0.01% 1024
2015
Q2
Sell
-352,751
Closed -$3.16M 1766
2015
Q1
$3.16M Buy
352,751
+110,319
+46% +$799K 0.11% 251
2014
Q4
$1.48M Buy
+242,432
New +$2.22M 0.06% 491
2014
Q2
Sell
-34,268
Closed -$511K 1580
2014
Q1
$511K Buy
+34,268
New +$540K 0.03% 734
2013
Q4
Sell
-93,173
Closed -$1.58M 1568
2013
Q3
$1.58M Sell
93,173
-73,571
-44% -$1.29M 0.09% 338
2013
Q2
$2.77M Buy
+166,744
New +$2.7M 0.09% 309

Other funds holding IMGN

A.R.T. Advisors's IMGN Position: Q1 2020 in Review

A.R.T. Advisors sold out of Immunogen Inc (IMGN) in Q1 2020, closing a stake of 112,765 shares — an estimated $576K sold.

A.R.T. Advisors first reported a position in IMGN in Q2 2013 and held it in 13 quarters. The position peaked at $3.16M in Q1 2015. 185 funds tracked by Wall St. Rank hold IMGN as of Q1 2020.

  • A.R.T. Advisors reported no remaining Immunogen Inc position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 112,765 Immunogen Inc shares in Q1 2020, an estimated $576K.
  • A.R.T. Advisors first reported a position in Immunogen Inc in Q2 2013 and held it in 13 quarters.
  • A.R.T. Advisors's Immunogen Inc position peaked at $3.16M in Q1 2015.
  • 185 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.